Efficacy, immunogenicity, and safety of a plant-derived,...

  • Main
  • 2020 / 10
  • Efficacy, immunogenicity, and safety of a plant-derived,...
Lancet (London, England) 2020 / 10

Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18–64 years) and older adults (≥65 years): two multicentre, randomised phase 3 trials

Ward, Brian J, Makarkov, Alexander, Séguin, Annie, Pillet, Stéphane, Trépanier, Sonia, Dhaliwall, Jiwanjeet, Libman, Michael D, Vesikari, Timo, Landry, Nathalie
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
The Lancet
DOI:
10.1016/S0140-6736(20)32014-6
Date:
October, 2020
File:
PDF, 787 KB
2020
Conversion to is in progress
Conversion to is failed